Towards Healthcare
U.S. Genotyping Market Size Leads by 13.72% CAGR till 2034

U.S. Genotyping Market Size, Emerging Opportunities and Competitive Landscape

Projections indicate that, the global U.S. genotyping market will increase from USD 7.33 billion in 2024 to USD 26.53 billion by 2034, experiencing a CAGR of 13.72% over the next 10 years. The increasing importance of genotyping in biotechnology and healthcare is driving the market’s growth.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

U.S. Genotyping Market Assessment

  • Overview
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Instruments
    • Reagents & Kits
    • Software and Services
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • PCR
    • Capillary Electrophoresis
    • Microarrays
    • Sequencing
    • Mass Spectrometry
    • Others
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Pharmacogenomics
    • Diagnostics and Personalized Medicine
    • Agricultural Biotechnology
    • Animal Genetics
    • Others
  • U.S. Genotyping Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Pharmaceutical and Biopharmaceutical Companies
    • Diagnostics and Research Laboratories
    • Academic Institutes
    • Others

Company Profiles

  • Bio-Rad Laboratories Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • GE Healthcare Inc.
  • Eurofins Scientific Inc.
  • Agilent Technologies
  • Danaher Corporation
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.

Conclusion & Recommendations

  • Insight Code: 5160
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: April 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

There are three types of genotypes: homozygous dominant (PP), homozygous recessive (pp) and heterozygous (Pp).

Genetic testing of skin, hair, blood, amniotic fluid or other tissues is used for the detection of genotypes.

Molecular beacons, DNA sequencing, SNP microarrays, mass spectrometry and PCR-based methods.

National Institute of Environmental Health Sciences, Centers for Disease Control and Prevention, American Society of Hematology, National Cancer Institute and National Institute of Health.